One particularly popular ETF is the Vanguard Value ETF (NYSEMKT: VTV). I do like it myself, but I'm a bit more jazzed by the ...

We came across a bullish thesis on Verve Therapeutics, Inc. on Stock Region Research’s Substack by Stock Region. In this ...

Analysts have also weighed in on stock throughout the month. Recent analyst calls on the stock include: Needham analyst Gil ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the 10 Stocks Going Wild. Crispr Therapeutics rallied for a second day on ...

CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest ...

Cathie Wood's ARKK hits a 52-week high after bold biotech moves, signaling renewed momentum in disruptive tech.

Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...

The largest transaction of the day was ARK’s acquisition of 102,806 shares of CRISPR Therapeutics AG (NASDAQ: CRSP ), valued at approximately $5.26 million. This purchase through the ARKK ETF reflects ...

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best CRISPR stocks to buy. Following CRISPR Therapeutics AG (NASDAQ:CRSP ...

The secret to retiring a multi-millionaire is quite simple. There is no easier way to accomplish this than by using a ...

Two growth stocks in the healthcare industry stand out in particular. Here is what you need to know about each one and why ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $42.5 and $55.0 for CRISPR Therapeutics, spanning the last three ...